comparemela.com

Latest Breaking News On - Phase 1 2 everest study - Page 1 : comparemela.com

Dr Fakih on the BASECAMP-1 Study in HLA-A*0201-Positive Solid Tumors

Marwan G. Fakih, MD, discusses the main objective and design of the observational BASECAMP-1 study and how it functions alongside the phase 1/2 EVEREST-1 study in patients with solid tumors.

Judy bernard briskinMarwang fakihClinical researchGastrointestinal cancer programJudy bernard briskin centerBernard briskinBernard briskin centerCity of hopeOnclive tvGastrointestinal cancerSolid tumorsBasecamp 1Phase 1 2 everest study

First Patient Dosed in EVEREST-1 Trial of A2B530 in Solid Tumors

The first patient has been dosed with the autologous CAR T-cell therapy A2B530 in the multicenter, first-in-human, phase 1/2 EVEREST-1 study.

J randolph hechtScott forakerGastrointestinal gi oncology programDavid geffen school of medicineBiotherapeutics incOncology programDavid geffen schoolAccessed junePhase 1 2 everest study

vimarsana © 2020. All Rights Reserved.